NASDAQ:QCOR - Questcor Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company is focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Its primary product is H.P. Acthar Gel (repository corticotropin injection), or Acthar, an injectable drug that is approved by the United States food and drug administration (FDA), for the treatment of 19 indications. Its research and development program is focused on: the evaluation of the use of Acthar for certain on-label indications; the investigation of other potential uses of Acthar for indications not FDA approved; and the expansion of its understanding of how Acthar works in the human body (pharmacology), and ultimately, its mechanisms of action in the disease states for which it is used, or may be used in the future. The Company sells Doral to pharmaceutical wholesalers, which resell Doral primarily to retail pharmacies and hospitals.

Receive QCOR News and Ratings via Email

Sign-up to receive the latest news and ratings for QCOR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
Current SymbolNASDAQ:QCOR
Previous Symbol
CUSIP74835Y10
Phone+1-714-7864200

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

Questcor Pharmaceuticals (NASDAQ:QCOR) Frequently Asked Questions

What is Questcor Pharmaceuticals' stock symbol?

Questcor Pharmaceuticals trades on the NASDAQ under the ticker symbol "QCOR."

Has Questcor Pharmaceuticals been receiving favorable news coverage?

Media headlines about QCOR stock have been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Questcor Pharmaceuticals earned a daily sentiment score of -1.2 on InfoTrie's scale. They also assigned news coverage about the biopharmaceutical company a news buzz of 3.0 out of 10, meaning that recent media coverage is unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of Questcor Pharmaceuticals?

Shares of QCOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Questcor Pharmaceuticals' official website?

The official website for Questcor Pharmaceuticals is http://www.mallinckrodt.com.

How can I contact Questcor Pharmaceuticals?

Questcor Pharmaceuticals' mailing address is 1300 N Kellogg Dr Ste D, ANAHEIM, CA 92807-1965, United States. The biopharmaceutical company can be reached via phone at +1-714-7864200.


MarketBeat Community Rating for Questcor Pharmaceuticals (NASDAQ QCOR)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  312 (Vote Outperform)
Underperform Votes:  138 (Vote Underperform)
Total Votes:  450
MarketBeat's community ratings are surveys of what our community members think about Questcor Pharmaceuticals and other stocks. Vote "Outperform" if you believe QCOR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QCOR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel